WHO Clears Rabies Vaccine Of India’s Zydus Cadila
This article was originally published in PharmAsia News
Executive Summary
The World Health Organization has cleared India's Zydus Cadila to sell its Lyssavac rabies vaccine to United Nations agencies. The clearance makes Zydus, part of Zydus Cadila Group, the first Indian company approved for UN sales. Zydus markets the vaccine, produced in collaboration with Berna Biotech of Switzerland, in India as Vaxirab. Outside of India, the vaccine is available only in South Asia and Africa. (Click here for more